ArticleClinicoEconomics and outcomes research : CEOR2013

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US.

Ken O'Day et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.